T. ISHIZAKI

485 citations
10 papers · 398 indexed · h-index 7

T. ISHIZAKI

10 papers receiving 390 citations

Peers

T. ISHIZAKI
Comparison fields: 5 of 73
  • Infectious Diseases 112
  • Pharmacology 52
  • Agronomy and Crop Science 48
  • Epidemiology 146
  • Biomedical Engineering 150
Replace Sang-Gu Yeo with:
Sang-Gu Yeo South Korea
Shuqi Xiao China
Nidhi Sharma India
Yiyu Lu China
Chonsaeng Kim South Korea
Mazhar Hussain New Zealand
Chee Keng Mok Singapore
Jeong‐Im Sin South Korea
Thomas Julien France
T. ISHIZAKI relative to Sang-Gu Yeo South Korea Sang-Gu Yeo's profile →
Citations per field
00.5×5.4×
Sang-Gu Yeo · 1×
Citations per year

Countries citing papers authored by T. ISHIZAKI

Since Specialization
Citations

This map shows the geographic impact of T. ISHIZAKI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. ISHIZAKI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. ISHIZAKI more than expected).

Fields of papers citing papers by T. ISHIZAKI

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. ISHIZAKI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. ISHIZAKI. The network helps show where T. ISHIZAKI may publish in the future.

Co-authorship network

The 25 scholars most cited alongside T. ISHIZAKI, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with T. ISHIZAKI Line = papers co-authored together T. ISHIZAKI links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 2007110
2 2006158
3
[A case of lymphocytic interstitial pneumonia with Sjögren's syndrome and systemic lupus erythematosus in which human herpes virus-6 infection was the suspected pathogen].
20016
4
Surveillance of poliovirus-isolates in Japan, 2000.
20013
5 19991
6 19981
7 199618
8 199681
9
Recent advances in structure activity relationships in new quinolones.
199214
10 19846

About T. ISHIZAKI

T. ISHIZAKI is a scholar working on Pharmaceutical Science, Biochemistry and Hepatology, having authored 10 papers that have together received 398 indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (2 papers), Influenza Virus Research Studies (2 papers), Respiratory viral infections research (2 papers), Biosensors and Analytical Detection (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Synthesis and Biological Evaluation (2 papers), Cancer therapeutics and mechanisms (1 paper) and Synthesis and biological activity (1 paper). The work is most often cited by research in Infectious Diseases (112 citations), Pharmacology (52 citations) and Agronomy and Crop Science (48 citations). T. ISHIZAKI has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Masaki Imai, Ai Ninomiya, Takato Odagiri, Tsugunori Notomi, Masato Tashiro, Masato Tashiro, Phan Văn Tú, Nguyen Thi Kim Tien, Diarmuid O’Shea and G R Wilkinson. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Vaccine and Journal of Virological Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026